SenzaGen AB
Research SenzaGen AB (SENZA) on Bullrun: market cap SEK 167.09M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSENZA
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencySEK
- Market capSEK 167.09M
- Financial periodQ1 2026
- RevenueSEK 14.96M
- Net income-SEK 1.92M
- Free cash flow-SEK 4.56M
- Gross margin69.0%
Valuation Snapshot
latest market cap is SEK 167.09M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 57.97M | -SEK 15.95M | -SEK 14.59M | 64.8% | -0.54 | SEK 26.78M | SEK 18.87M | SEK 77.73M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | SEK 167.09M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About SenzaGen AB
SenzaGen AB provides non-animal tests for assessing allergenicity. The company offers GARD skin OECD 442E, GARD skin dose-response, GARD skin medical device; and GARD air, a respiratory sensitization assessment. It also provides biological evaluation, in vitro biocompatibility testing, cytotoxicity, irritation, and skin sensitization medical device services; advisory services for medical devices; and substance based medical devices.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SenzaGen AB's market cap?
SenzaGen AB's market capitalization is SEK 167.09M.
What does SenzaGen AB do?
SenzaGen AB provides non-animal tests for assessing allergenicity. The company offers GARD skin OECD 442E, GARD skin dose-response, GARD skin medical device; and GARD air, a respiratory sensitization assessment. It also provides biological evaluation, in vitro biocompatibility testing, cytotoxicity, irritation, and skin sensitization medical device services; advisory services for medical devices; and substance based medical devices.